Fetal Neural Grafts for the Treatment of Huntington's Disease

[1]  O. Lindvall.  Neural transplantation in Parkinson's disease. , 2008, Novartis Foundation symposium.

[2]  Françoise Condé,et al.  Fetal striatal allografts reverse cognitive deficits in a primate model of Huntington disease , 1998, Nature Medicine.

[3]  M. Peschanski,et al.  Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease , 1997, Nature.

[4]  E. Grasbon-Frodl,et al.  DARPP-32-rich zones in grafts of lateral ganglionic eminence govern the extent of functional recovery in skilled paw reaching in an animal model of Huntington's disease , 1996, Neuroscience.

[5]  O. Lindvall,et al.  Phenotypic development of the human embryonic striatal primordium: A study of cultured and grafted neurons from the lateral and medial ganglionic eminences , 1996, Neuroscience.

[6]  E. Mufson,et al.  Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, ultrastructural, and metabolic studies , 1996, The Journal of comparative neurology.

[7]  M. Beal,et al.  Chronic 3-Nitropropionic Acid Treatment in Baboons Replicates the Cognitive and Motor Deficits of Huntington’s Disease , 1996, The Journal of Neuroscience.

[8]  P. Brundin,et al.  Paucity of P-zones in striatal grafts prohibit commencement of clinical trials in Huntington's disease , 1996, Neuroscience.

[9]  C. Olanow,et al.  Fetal nigral transplantation as a therapy for Parkinson's disease , 1996, Trends in Neurosciences.

[10]  O. Lindvall,et al.  Core assessment program for intracerebral transplantation in Huntington's disease (CAPIT‐HD) , 1996, Movement disorders : official journal of the Movement Disorder Society.

[11]  C. Ross,et al.  Neurobiology of Huntington's Disease , 1996, Neurobiology of Disease.

[12]  Y. Samson,et al.  Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. , 1996, Brain : a journal of neurology.

[13]  D. Riche,et al.  Ontogeny of Human Striatal DARPP-32 Neurons in Fetuses and Following Xenografting to the Adult Rat Brain , 1996, Experimental Neurology.

[14]  A. Björklund,et al.  Projection neurons in fetal striatal transplants are predominantly derived from the lateral ganglionic eminence , 1995, Neuroscience.

[15]  Vincent Frouin,et al.  Clinical correlates of {18F}fluorodopa uptake in five grafted Parkinsonian patients , 1995, Annals of neurology.

[16]  I. Shoulson,et al.  A prospective evaluation of cognitive decline in early Huntington's disease , 1995, Neurology.

[17]  F. Vingerhoets,et al.  Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease , 1995, Annals of neurology.

[18]  M. Peschanski,et al.  Effects of target deprivation on the morphology and survival of adult dorsal column nuclei neurons , 1995, The Journal of comparative neurology.

[19]  P R Sanberg,et al.  Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. , 1995, The New England journal of medicine.

[20]  A. Björklund,et al.  Neurotransmitter-related gene expression in intrastriatal striatal transplants—II. Characterization of efferent projecting graft neurons , 1995, Neuroscience.

[21]  O. Isacson,et al.  The lateral ganglionic eminence is the origin of cells committed to striatal phenotypes: neural transplantation and developmental evidence , 1994, Brain Research.

[22]  P. Brundin,et al.  Lazaroids improve the survival of grafted rat embryonic dopamine neurons. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Peschanski,et al.  Fine structural alteration in target-deprived axonal terminals in the rat thalamus , 1994, Neuroscience.

[24]  M. Peschanski,et al.  Target dependence of adult neurons: pattern of terminal arborizations , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  Y. Samson,et al.  Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon. , 1994, Brain : a journal of neurology.

[26]  Richard S. J. Frackowiak,et al.  Evidence for long‐term survival and function of dopaminergic grafts in progressive Parkinson's disease , 1994, Annals of neurology.

[27]  M. Sasaki,et al.  Cerebral glucose metabolism and striatal 18F-Dopa uptake by PET in cases of chorea with or without dementia , 1993, Journal of the Neurological Sciences.

[28]  E. R. Kandel,et al.  Synaptic transmission: A bidirectional and self-modifiable form of cell-cell communication , 1993, Cell.

[29]  A. Björklund,et al.  Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) , 1992, The New England journal of medicine.

[30]  Scott T. Grafton,et al.  Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. , 1992, The New England journal of medicine.

[31]  D. Spencer,et al.  Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. , 1992, The New England journal of medicine.

[32]  M. Peschanski,et al.  Host dopaminergic afferents affect the development of DARPP-32 immunoreactivity in transplanted embryonic striatal neurons , 1992, Neuroscience.

[33]  D. Riche,et al.  Intrastriatal transplantation of cross-species fetal striatal cells reduces abnormal movements in a primate model of Huntington disease. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Richard S. J. Frackowiak,et al.  Transplantation of fetal dopamine neurons in Parkinson's disease: PET {18F}6‐L‐fluorodopa studies in two patients with putaminal implants , 1992, Annals of neurology.

[35]  T. Robbins,et al.  Striatal Graft‐Associated Recovery of a Lesion‐Induced Performance Deficit in the Rat Requires Learning to Use The Transplant , 1992, The European journal of neuroscience.

[36]  Richard S. J. Frackowiak,et al.  Transplantation of fetal dopamine neurons in Parkinson's disease: One‐year clinical and neurophysiological observations in two patients with putaminal implants , 1992, Annals of neurology.

[37]  A. Björklund,et al.  Development of intrastriatal striatal grafts and their afferent innervation from the host , 1991, Neuroscience.

[38]  D. Salmon,et al.  The nature of the naming deficit in Alzheimer's and Huntington's disease. , 1991, Brain : a journal of neurology.

[39]  D. Sax,et al.  Factors associated with slow progression in Huntington's disease. , 1991, Archives of neurology.

[40]  C. Clough,et al.  Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson's disease. , 1991, Archives of neurology.

[41]  C. Randolph.  Implicit, explicit, and semantic memory functions in Alzheimer's disease and Huntington's disease. , 1991, Journal of clinical and experimental neuropsychology.

[42]  R. S. Williams,et al.  Morphometric analysis of the prefrontal cortex in Huntington's disease , 1991, Neurology.

[43]  Y. Agid,et al.  Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy , 1991, Neurology.

[44]  J. Bennett,et al.  Development of D1 and D2 dopamine receptors and associated second messenger systems in fetal striatal transplants , 1991, Experimental Neurology.

[45]  S. Hunt,et al.  Gene expression in striatal grafts—I. Cellular localization of neurotransmitter mRNAs , 1990, Neuroscience.

[46]  J. Bennett,et al.  Fetal neostriatal transplants in the rat: A light and electron microscopic Golgi study , 1990, Neuroscience.

[47]  A. Björklund,et al.  Fetal striatal neurons grafted into the ibotenate lesioned adult striatum: Efferent projections and synaptic contacts in the host globus pallidus , 1990, Neuroscience.

[48]  N Butters,et al.  Differential impairment of semantic and episodic memory in Alzheimer's and Huntington's diseases: a controlled prospective study. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[49]  R. Roberts,et al.  Long-term survival of GABA-, enkephalin-, NADPH-diaphorase- and calbindin-d28k-containing neurons in fetal striatal grafts , 1990, Brain Research.

[50]  Scott T. Grafton,et al.  A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease , 1990, Annals of neurology.

[51]  R. Faull,et al.  Haloperidol induces Fos and related molecules in intrastriatal grafts derived from fetal striatal primordia , 1990, Brain Research.

[52]  V. Bracha,et al.  Unilateral striatal grafts induce behavioral and electrophysiological asymmetry in rats with bilateral kainate lesions of the caudate nucleus. , 1990, Behavioral neuroscience.

[53]  H. Herzog,et al.  Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. , 1990, Brain : a journal of neurology.

[54]  M. T. Shipley,et al.  Neural grafts and pharmacological intervention in a model of Huntington's disease , 1990, Brain Research Bulletin.

[55]  D. Salmon,et al.  Pictorial priming and cued recall in Alzheimer's and Huntington's disease , 1990, Brain and Cognition.

[56]  Scott T. Grafton,et al.  Transplantation of human fetal dopamine cells for Parkinson's disease. Results at 1 year. , 1990, Archives of neurology.

[57]  A. Graybiel,et al.  Intrastriatal grafts derived from fetal striatal primordia: II. Reconstitution of cholinergic and dopaminergic systems , 1990, The Journal of comparative neurology.

[58]  R. Heavens,et al.  Autoradiographic localisation of D1 and D2 dopamine receptors in primordial striatal tissue grafts in rats , 1990, Neuroscience Letters.

[59]  C D Marsden,et al.  Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. , 1990, Science.

[60]  M. Cudkowicz,et al.  Degeneration of pyramidal projection neurons in Huntington's disease cortex , 1990, Annals of neurology.

[61]  A. Björklund,et al.  Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum—III. Efferent projecting graft neurons and their relation to host afferents within the grafts , 1989, Neuroscience.

[62]  F. Zhou,et al.  Connectivities of the striatal grafts in adult rat brain: a rich afference and scant striatonigral efference , 1989, Brain Research.

[63]  A. Björklund,et al.  Intrinsic Organization and Connectivity of Intrastriatal Striatal Transplants in Rats as Revealed by DARPP‐32 Immunohistochemistry: Specificity of Connections with the Lesioned Host Brain , 1989, The European journal of neuroscience.

[64]  J. Illes.  Neurolinguistic features of spontaneous language production dissociate three forms of neurodegenerative disease: Alzheimer's, Huntington's, and Parkinson's , 1989, Brain and Language.

[65]  L. Thal,et al.  Differentiation of Alzheimer's disease and Huntington's disease with the Dementia Rating Scale. , 1989, Archives of neurology.

[66]  D. Salmon,et al.  A comparison of the category fluency deficits associated with Alzheimer's and Huntington's disease , 1989, Brain and Language.

[67]  M. Giordano,et al.  Fetal striatal tissue grafts into excitotoxin-lesioned striatum: Pharmacological and behavioral aspects , 1989, Pharmacology Biochemistry and Behavior.

[68]  A. Graybiel,et al.  Intrastriatal grafts derived from fetal striatal primordia. I. Phenotypy and modular organization , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[69]  Hitoshi Takahashi,et al.  A quantitative investigation of the substantia nigra in Huntington's disease , 1989, Annals of neurology.

[70]  Richard S. J. Frackowiak,et al.  PET and movement disorders. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[71]  S. Plumb,et al.  A controlled clinical trial of baclofen as protective therapy in early huntington's disease , 1989, Annals of neurology.

[72]  D. Salmon,et al.  Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[73]  E. Eidelberg,et al.  Transsynaptic degeneration of motoneurones caudal to spinal cord lesions , 1989, Brain Research Bulletin.

[74]  E. Granholm,et al.  Retrograde amnesia in patients with Alzheimer's disease or Huntington's disease , 1988, Neurobiology of Aging.

[75]  J. Noth,et al.  Language functions in Huntington's disease. , 1988, Brain : a journal of neurology.

[76]  R. Robinson,et al.  Receptor characteristics and recovery of function following kainic acid lesions and fetal transplants of the striatum. II. Dopaminergic systems , 1988, Brain Research.

[77]  A. Björklund,et al.  Connectivity of striatal grafts implanted into the ibotenic acid-lesioned striatum—I. Subcortical afferents , 1988, Neuroscience.

[78]  M. Peschanski,et al.  Morphological alteration of thalamic afferents in the excitotoxically lesioned striatum , 1988, Brain Research.

[79]  P. Sharp,et al.  Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[80]  J. Vonsattel,et al.  Morphometric Demonstration of Atrophic Changes in the Cerebral Cortex, White Matter, and Neostriatum in Huntington's Disease , 1988, Journal of neuropathology and experimental neurology.

[81]  R. Roberts,et al.  Localization of immunoreactive GABA and enkephalin and NADPH‐Diaphorase‐positive neurons in fetal striatal grafts in the quinolinic‐acid‐lesioned rat neostriatum , 1988, The Journal of comparative neurology.

[82]  R. Hichwa,et al.  Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function , 1988, Annals of neurology.

[83]  S. Folstein,et al.  Differential cognitive impairment in alzheimer's disease and huntington's disease , 1988, Annals of neurology.

[84]  E. Granholm,et al.  Associative encoding and retrieval in Alzheimer's and Huntington's disease , 1988, Brain and Cognition.

[85]  S. P. Hunt,et al.  Immunocytochemical studies on the basal ganglia and substantia nigra in Parkinson's disease and Huntington's chorea , 1988, Neuroscience.

[86]  A. Björklund,et al.  Striatal grafts in rats with unilateral neostriatal lesions—III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching , 1988, Neuroscience.

[87]  M. Giordano,et al.  Striatal tissue transplants attenuate apomorphine-induced rotational behavior in rats with unilateral kainic acid lesions , 1988, Neuropharmacology.

[88]  A. Björklund,et al.  Striatal grafts in rats with unilateral neostriatal lesions—II. In vivo monitoring of gaba release in globus pallidus and substantia nigra , 1988, Neuroscience.

[89]  A. Björklund,et al.  Striatal grafts in rats with unilateral neostriatal lesions—I. Ultrastructural evidence of afferent synaptic inputs from the host nigrostriatal pathway , 1988, Neuroscience.

[90]  D. Weinberger,et al.  Prefrontal cortical blood flow and cognitive function in Huntington's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[91]  M. Garcia-Munoz,et al.  Electrophysiological demonstration of host cortical inputs to striatal grafts , 1987, Neuroscience Letters.

[92]  F. Gage,et al.  Neural grafting in a rat model of huntington's disease: Striosomal-like organization of striatal grafts as revealed by acetylcholinesterase histochemistry, immunocytochemistry and receptor autoradiography , 1987, Neuroscience.

[93]  M. Giordano,et al.  Multiple Transplants of Fetal Striatal Tissue in the Kainic Acid Model of Huntington's Disease , 1987 .

[94]  J. McAllister,et al.  Identification of acetylcholinesterase‐reactive neurons and neuropil in neostriatal transplants , 1987, The Journal of comparative neurology.

[95]  J. Besson,et al.  Structural alteration and possible growth of afferents after kainate lesion in the adult rat thalamus , 1987, The Journal of comparative neurology.

[96]  J. Mazziotta,et al.  Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. , 1987, The New England journal of medicine.

[97]  P. Sanberg,et al.  Locomotor hyperactivity: Effects of multiple striatal transplants in an animal model of Huntington's disease , 1986, Pharmacology Biochemistry and Behavior.

[98]  M. Hayden,et al.  Positron emission tomography in the early diagnosis of Huntington's disease , 1986, Neurology.

[99]  A. Björklund,et al.  Graft-induced behavioral recovery in an animal model of Huntington disease. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[100]  R. Marchand,et al.  Histogenesis of the striopallidal system in the rat. Neurogenesis of its neurons , 1986, Neuroscience.

[101]  R. Robinson,et al.  Behavioral recovery following kainic acid lesions and fetal implants of the striatum occurs independent of dopaminergic mechanisms , 1986, Brain Research.

[102]  F. Gage,et al.  Neural grafting in a rat model of huntington's disease: Progressive neurochemical changes after neostriatal ibotenate lesions and striatal tissue grafting , 1985, Neuroscience.

[103]  M. C. Zemanick,et al.  Morphology of embryonic neostriatal cell suspensions transplanted into adult neostriata. , 1985, Brain research.

[104]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[105]  F. Gage,et al.  Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum , 1984, Nature.

[106]  A. Young,et al.  A polymorphic DNA marker genetically linked to Huntington's disease , 1983, Nature.

[107]  J. Coyle,et al.  Reversal of long-term locomotor abnormalities in the kainic acid model of Huntington's disease by day 18 fetal striatal implants. , 1983, European journal of pharmacology.

[108]  C. Markham,et al.  Cerebral metabolism and atrophy in huntington's disease determined by 18FDG and computed tomographic scan , 1982, Annals of neurology.

[109]  K. F. Schroeder,et al.  Morphometric studies of the neuropathological changes in choreatic diseases , 1976, Journal of the Neurological Sciences.

[110]  R. Dom,et al.  Neuropathology of Huntington's chorea , 1976, Neurology.

[111]  W. Mccaughey.  THE PATHOLOGIC SPECTRUM OF HUNTINGTON'S CHOREA , 1961 .

[112]  W. Hewitt.  The development of the human internal capsule and lentiform nucleus. , 1961, Journal of anatomy.

[113]  W. Hewitt.  The development of the human caudate and amygdaloid nuclei. , 1958, Journal of anatomy.

[114]  E. R. Cooper,et al.  THE DEVELOPMENT OF THE HUMAN RED NUCLEUS AND CORPUS STRIATUM , 1946 .

[115]  Charles B. Dunlap.  PATHOLOGIC CHANGES IN HUNTINGTON'S CHOREA: WITH SPECIAL REFERENCE TO THE CORPUS STRIATUM , 1927 .

[116]  J. Johnston.  Further contributions to the study of the evolution of the forebrain , 1923 .

[117]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.

[118]  J. Gusella,et al.  Huntington's disease. , 1995, Seminars in cell biology.

[119]  D. Brooks,et al.  Core assessment program for intracerebral transplantations (CAPIT) , 1992, Movement disorders : official journal of the Movement Disorder Society.

[120]  S. Dunnett,et al.  Effects of nigral and striatal grafts on skilled forelimb use in the rat. , 1990, Progress in brain research.

[121]  S. Dunnett,et al.  Ultrastructural organization within intrastriatal striatal grafts. , 1990, Progress in brain research.

[122]  C D Marsden,et al.  Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography , 1986, Movement disorders : official journal of the Movement Disorder Society.

[123]  R. Sturrock,et al.  Ontogeny of the Neostriatum , 1979 .